RE:Start Reading Doubters " The company Oncolytics Biotech has performed two successful phase 2 trials of a tumor-attacking reovirus, combined with various types of chemotherapy and checkpoint inhibitors, in patients with breast cancer or pancreatic cancer. The company hopes to begin phase III trials of the virus for both cancer types as soon as 2024."